AstraZeneca oldie Faslodex nets another breast cancer approval

29th August 2017 Uncategorised 0

AstraZeneca may have recently hit a snag in the immuno-oncology space, but it got a boost Monday elsewhere in its cancer portfolio.

More: AstraZeneca oldie Faslodex nets another breast cancer approval
Source: fierce